Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is injected once a week, on the same chosen day each week, every week. That rhythm stays fixed from your first 2.5 mg starter dose through to whatever maintenance dose your prescriber establishes over time. One injection, seven days apart, repeated consistently — that is the full answer to how often to inject Mounjaro. Because it is a prescription-only medicine, a prescriber decides whether it is right for you before treatment begins, and guides every dose change from there. The NHS tirzepatide medicines page confirms this once-weekly schedule and is a reliable first-stop reference.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Once you know Mounjaro is injected once a week, the practical question becomes simpler: which day works for your life? Some people pick Monday to start the week with a routine; others prefer a weekend morning when they have time to sit with it. The day itself does not change how the medicine behaves. What matters is consistency, injecting roughly 168 hours after the previous one keeps the drug level steady in your system.
There is a common misconception worth clearing up gently here: some people assume the dose titration schedule means they will be injecting more frequently as treatment progresses. It does not. The frequency is always once a week. What changes over roughly four-week intervals is the strength of each injection, not how often you give it. Treatment starts at 2.5 mg (a dose that exists to let your body adjust rather than to drive weight loss) and a prescriber steps it up in stages based on how you tolerate each level. You can read more about how the Mounjaro injection itself works if you want the fuller picture on mechanism and technique.
The decision about day and time is genuinely yours. Evening injections suit people who prefer to sleep through any initial nausea from a new dose. Morning injections fit those who like to track things at the start of the day. Both work. Fix the day, set a phone reminder, and the schedule largely takes care of itself.
The standard UK titration for Mounjaro runs through six possible strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. A prescriber typically holds each dose for around four weeks before considering an increase, and at every point in that process, you are still injecting once a week. The frequency never changes; only the number printed on the pen does.
Each KwikPen is pre-filled with four weekly doses, so one pen covers a calendar month. If you want to understand how often the Mounjaro injection is given and what drives the timing of any escalation, that is a question for your prescriber at each clinical review, because tolerance, side-effect profile and progress all feed into the decision. The BNF entry for tirzepatide sets out the licensed dose ranges for UK prescribers, and your Patient Information Leaflet covers the practical steps in detail.
If you are thinking about the cost picture alongside this (one pen per month, one clinical review per repeat) there is a plain breakdown of what private treatment through nume includes on our treatments page. The frequency of injection and the frequency of clinical oversight are both part of the same service.
Each weekly injection goes into the fatty tissue just under the skin, the abdomen, the front of the thigh, or the upper arm are the three licensed sites. Rotating between sites with each weekly injection matters: repeatedly using the same small spot can cause local skin changes over time. So the once-weekly rhythm pairs naturally with a rotation habit: week one abdomen, week two thigh, week three upper arm, and so on.
The KwikPen is designed to make the injection itself straightforward. If you are curious how often you inject tirzepatide and what a realistic weekly routine looks like around that, keeping to the same day, rotating your site, and storing the pen safely in the fridge between uses reduces the friction that makes people skip doses. Storage stays refrigerated at 2–8 °C; room-temperature handling windows are specified in the SmPC and PIL rather than a figure to quote here. If you are building your weekly kit, having alcohol swabs to hand for site preparation is good practice.
People who have transferred from another provider, or who are increasing their dose, sometimes ask how often you inject Mounjaro for weight loss, as in, could they inject more than once a week to speed things up. The answer is no. The licensed schedule is one injection per seven days, and exceeding that does not accelerate results; it increases risk. A prescriber will tell you the same thing, and it is one reason clinical review before every repeat matters rather than just automated re-ordering. Our FAQs cover a few related questions if you want to keep reading.
Life interrupts schedules. Travel, illness and simply forgetting are all real. If you miss a Mounjaro injection, the Patient Information Leaflet specifies a window during which a late dose can still be given, and what to do if that window has passed. The rule is not to double-dose to compensate. Beyond that level of detail, the right person to call is your prescriber or a pharmacist, not a dosing forum.
Elective surgery is a separate consideration: NHS England guidance advises telling your surgeon and anaesthetist that you take a GLP-1 medicine, because gastric-emptying effects are relevant to anaesthesia safety. That conversation should happen well in advance of any procedure, and your prescriber can advise on timing. If you are still at the early-research stage, our page on the Mounjaro slimming injection covers its licence, clinical evidence and suitability criteria in one place.
For anyone wondering whether tirzepatide specifically is the right direction for them, or whether a different treatment might suit better, our weight-loss treatments overview lays out the options in plain terms. And if you are ready to find out whether you are eligible, checking your eligibility through a free consultation is the next step, a GPhC-registered prescriber, not software, reads your answers and responds the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.